After Hours
$
5.81
Change
+0.07 +1.22%
Volume
Volume 1.76m
Nov 29, 2016, 5:51 p.m.
Quotes are delayed by 20 min
Today's close
$ 6.79
$ 5.74
Change
-1.05 -15.46%
Day low
Day high
$5.41
$6.50
52 week low
52 week high
$4.39
$11.26
Market cap
$1.33B
Average volume
2.07M
P/E ratio
N/A
Rev. per Employee
$168,023
EPS
-0.45
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on TXMD
-
Charting the bull-bear debate ahead of the Fed
- Michael Ashbaugh
-
TherapeuticsMD shares rally on menopause drug study data
- Wallace Witkowski
Analyst Ratings
-
- Benzinga
-
- Benzinga
Other News on TXMD
-
Biggest Movers in Manufacturing Stocks Now – GENE AEGR QLTI NOVN
- InvestorPlace.com
-
TherapeuticsMD (TXMD) Investor Presentation - Slideshow
- Seeking Alpha
-
17 Pharmaceuticals Stocks to Sell Now
- InvestorPlace.com
-
26 Pharmaceuticals Stocks to Sell Now
- InvestorPlace.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Is This Why Shares of TherapeuticsMD Inc. Rose Today?
- Motley Fool
-
Notable earnings after Thursday’s close
- Seeking Alpha
-
Here's Why TherapeuticsMD Inc. Fell 11.5% in August
- Motley Fool
-
Biggest Movers in Manufacturing Stocks Now – RIGL SYRS KPTI OREX
- InvestorPlace.com
-
- Edgar Online - (EDG = 10Q, 10K)
-
Notable earnings after Thursday’s close
- Seeking Alpha
-
TherapeuticsMD files NDA for estradiol capsule for dyspareunia
- Seeking Alpha
-
Four Biotech Picks With 2016 Catalysts
- Barrons.com
-
Notable earnings after Tuesday’s close
- Seeking Alpha
- Loading more headlines...
Press Releases on TXMD
-
TherapeuticsMD to Present at Two Upcoming Investor Conferences
- BusinessWire - BZX
-
TherapeuticsMD Expands Commercial and Business Development Leadership
- BusinessWire - BZX
-
TherapeuticsMD Announces Third Quarter 2016 Financial Results
- BusinessWire - BZX
-
Global Hormone Replacement Therapy (HRT) Industry
- PR Newswire - PRF
-
TherapeuticsMD Announces Second Quarter 2016 Financial Results
- BusinessWire - BZX
-
TherapeuticsMD to Host Second Quarter Financial Results
- BusinessWire - BZX
-
TherapeuticsMD Announces New Drug Application Submission for Yuvvexy™ (TX-004HR)
- BusinessWire - BZX
-
TherapeuticsMD Announces Filing Timeline for Yuvvexy (TX-004HR) New Drug Application
- BusinessWire - BZX
-
Global Hormone Replacement Therapy (HRT) Industry
- PR Newswire - PRF
-
TherapeuticsMD to Present at Two Upcoming Investor Conferences
- BusinessWire - BZX
-
TherapeuticsMD to Present at Two Upcoming Investor Conferences
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 12.00% | 12.00% | 11.96% |
| Business | 13.12% | 13.12% | 13.12% |
| Student | 13.42% | 13.42% | 13.42% |
| Balance Transfer | 14.41% | 14.41% | 14.39% |
| Airline | 15.13% | 15.13% | 15.17% |
| Reward | 15.24% | 15.24% | 15.30% |
| Cash Back | 15.33% | 15.33% | 15.30% |
| Instant Approval | 17.86% | 17.86% | 18.04% |
| Bad Credit | 22.86% | 22.86% | 22.56% |




